Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Hatzis

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Hormones (Athens, Greece)|April 30, 2014
Trends in metabolic syndrome risk factors among adolescents in rural Crete between 1989 and 2011Charis Girvalaki, Constantine Vardavas, Christopher Papandreou, et al.
British Journal of Cancer|March 22, 2018
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypesBalázs Győrffy, Lőrinc Pongor, Giulia Bottai, et al.
BMC Genomics|October 9, 2014
Statistical measures of transcriptional diversity capture genomic heterogeneity of cancerTingting Jiang, Weiwei Shi, René Natowicz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2015
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapyFlorentia Peintinger, Bruno Sinn, Christos Hatzis, et al.
Computational and Structural Biotechnology Journal|October 16, 2023
Evaluation of zero counts to better understand the discrepancies between bulk and single-cell RNA-Seq platformsJoanna Zyla, Anna Papiez, Jun Zhao, et al.
Breast Cancer Research and Treatment|February 6, 2015
Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancersSabrina S Khan, Thomas Karn, W Fraser Symmans, et al.
Breast Cancer Research and Treatment|April 26, 2019
Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapyMaysa M Abu-Khalaf, Anton Safonov, Jamie Stratton, et al.
JAMA Oncology|July 28, 2017
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast CancerThomas Karn, Tingting Jiang, Christos Hatzis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancerFlorentia Peintinger, Keith Anderson, Chafika Mazouni, et al.
Journal of the National Cancer Institute|October 29, 2011
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancersChristos Hatzis, Hongxia Sun, Hui Yao, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Hormones (Athens, Greece)|April 30, 2014
Trends in metabolic syndrome risk factors among adolescents in rural Crete between 1989 and 2011Charis Girvalaki, Constantine Vardavas, Christopher Papandreou, et al.
British Journal of Cancer|March 22, 2018
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypesBalázs Győrffy, Lőrinc Pongor, Giulia Bottai, et al.
BMC Genomics|October 9, 2014
Statistical measures of transcriptional diversity capture genomic heterogeneity of cancerTingting Jiang, Weiwei Shi, René Natowicz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2015
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapyFlorentia Peintinger, Bruno Sinn, Christos Hatzis, et al.
Computational and Structural Biotechnology Journal|October 16, 2023
Evaluation of zero counts to better understand the discrepancies between bulk and single-cell RNA-Seq platformsJoanna Zyla, Anna Papiez, Jun Zhao, et al.
Breast Cancer Research and Treatment|February 6, 2015
Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancersSabrina S Khan, Thomas Karn, W Fraser Symmans, et al.
Breast Cancer Research and Treatment|April 26, 2019
Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapyMaysa M Abu-Khalaf, Anton Safonov, Jamie Stratton, et al.
JAMA Oncology|July 28, 2017
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast CancerThomas Karn, Tingting Jiang, Christos Hatzis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancerFlorentia Peintinger, Keith Anderson, Chafika Mazouni, et al.
Journal of the National Cancer Institute|October 29, 2011
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancersChristos Hatzis, Hongxia Sun, Hui Yao, et al.
Pageof 10